Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Ron Squarer currently holds 12,000 shares of Travere Therapeutics, Inc. (TVTX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Ron Squarer has been a net seller of TVTX stock. They have purchased $74.4K and sold $20.7M worth of shares.
Ron Squarer's most recent insider trade was on Jul 15, 2026, when they sold 4,418 shares at $0.00 per share.
Ron Squarer serves as Executive at Travere Therapeutics, Inc. (TVTX). They have executed 74 insider transactions totaling $20.7M over their tenure at the company.
Ron Squarer holds the position of Executive at Travere Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 17 years and currently hold a stake valued at $0.
Ron Squarer has shown a selling trading pattern, with $74.4K in total purchases and $20.7M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Ron Squarer was on Jul 30, 2019, when they sold $12.5M worth of ARRY shares. This transaction involved 259,891 shares at $48.00 per share.
Ron Squarer currently owns 12,000 shares of Travere Therapeutics, Inc. (TVTX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Ron Squarer's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Ron Squarer has 74 Form 4 filings on record as an insider at Travere Therapeutics, Inc..
Set alerts for Ron Squarer and 40,000+ other insiders.